9 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 14 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 9, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Anorexia: new trials by email Literature Review of Anorexia trials Research Report on Anorexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss ponsegromab, placebo - Non-small Cell Lung Cancer (NSCLC), Cachexia | Phase 1 | Not yet recruiting | Pfizer | 80 | 2026-10-23 | 2026-09-25 |
| AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) Placebo, Low CBG, High CBG - Pain, Appetite Loss | Phase 1 | Active not recruiting | University of California, Los Angeles | 20 | 2023-02-15 | 2026-03-20 |
| Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) Sativex - Malnutrition, Anorexia | Phase 1 | Completed | Ove Andersen | 169 | 2022-03-24 | 2026-11-13 |
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia PF-06946860, Placebo for PF-06946860 - Non-small Cell Lung Cancer, Pancreatic Cancer | Phase 1 | Completed | Pfizer | 18 | 2021-05-11 | 2024-01-12 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. PF-06946860 - Cachexia, Non-Small-Cell Lung Cancer | Phase 1 | Completed | Pfizer | 11 | 2020-11-17 | 2023-12-14 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S QBS10072S - Astrocytoma, Brain Cancer | Phase 1 | Completed | Quadriga Biosciences, Inc. | 15 | 2020-07-20 | 2023-01-18 |
| PRE-GAiN Bone Health Pilot Study Estradiol Hemihydrate Transdermal System - Anorexia Nervosa | Phase 1 | Withdrawn | University of Saskatchewan | 2020-01-21 | 2022-12-16 | |
| Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia Nervosa Deep Brain Stimulation(DBS), Capsulotomy - Anorexia | Phase 1 | Unknown | Ruijin Hospital | 48 | 2012-04-01 | 2012-09-05 |
| Repetitive Transcranial Magnetic Stimulation of the DMPFC for Anorexia and Bulimia: an Open-Label Case Series Repetitive Transcranial Magnetic Stimulation - Bulimia Nervosa, Anorexia Nervosa | Phase 1 | Completed | University Health Network, Toronto | 60 | 2011-12-11 | 2020-06-01 |
| Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers Megace F, Megace OS - Cachexia, Anorexia | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 103 | 2011-07-01 | 2012-07-02 |
| Paullinia Cupana for Anorexia in Oncologic Patients Paullinia cupana - Cancer-related Problem/Condition, Anorexia | Phase 1 / Phase 2 | Unknown | Faculdade de Medicina do ABC | 35 | 2011-04-01 | 2012-02-28 |
| Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects Sertraline plus Telenzepine - Obesity | Phase 1 | Completed | Theracos | 40 | 2010-05-01 | 2019-06-17 |
| Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults Rotavin - Diarrhea, Vomit | Phase 1 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 29 | 2009-08-01 | 2016-07-04 |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting Palonosetron - Melanoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 30 | 2006-11-01 | 2012-05-04 |
Weight Loss (6) · Cachexia (4) · Carcinoma, Non-Small-Cell Lung (3) · Colorectal Neoplasms (3) · Fatigue (3) · Neoplasms (3) · Pancreatic Neoplasms (3) · Vomiting (3) · Anorexia Nervosa (2) · Breast Neoplasms (2) · Melanoma (2) · Nausea (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2)
Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms, Digestive (14) · Signs and Symptoms (13) · Body Weight (7) · Body Weight Changes (7) · Neoplasms by Site (5) · Lung Diseases (4) · Mental Disorders (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thinness (4) · Thoracic Neoplasms (4) · Bronchial Neoplasms (3) · Carcinoma, Bronchogenic (3) · Colonic Diseases (3)
Deep Brain Stimulation (1) · Palonosetron (1) · Posterior Capsulotomy (1) · Sertraline (1) · Transcranial Magnetic Stimulation (1) · nabiximols (1) · telenzepine (1)
Pfizer (3) · Boryung Pharmaceutical Co., Ltd (1) · Faculdade de Medicina do ABC (1) · M.D. Anderson Cancer Center (1) · National Institute of Hygiene and Epidemiology, Vietnam (1) · Ove Andersen (1) · Quadriga Biosciences, Inc. (1) · Ruijin Hospital (1) · Theracos (1) · University Health Network, Toronto (1) · University of California, Los Angeles (1) · University of Saskatchewan (1)
United States (5) · Canada (2) · China (2) · Australia (1) · Brazil (1) · Denmark (1) · South Korea (1) · Vietnam (1)
Agop Y. Bedikian, MD (1) · Anh D Dang, PhD (1) · Blake Woodside, MD (1) · Bomin Sun, MD (1) · Claudia Latorre (1) · Jolene Berg, MD (1) · Jonathan Downar, MD (1) · Kyung-sang Yu, Dr. (1) · Munier Nour (1) · Ove Andersen (1) · Rikke L Nielsen (1) · Ziva D Cooper, PhD (1)